Mayank Mamtani
Stock Analyst at B. Riley Securities
(4.05)
# 1,676
Out of 4,556 analysts
1093
Total ratings
38.8%
Success rate
6.2%
Average return
Main Sectors:
Stocks Rated by Mayank Mamtani
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MANE Veradermics | Initiated Coverage: Buy | $170 | $112.54 | +51.06% | 1 | Jul 15, 2026 | |
| UNCY Unicycive Therapeutics | Maintained: Buy | $22 | $5.64 | +290.01% | 2 | Jun 30, 2026 | |
| KYMR Kymera Therapeutics | Rated: Buy | $117 → $155 | $111.34 | +39.21% | 4 | Jun 29, 2026 | |
| ELTX Elicio Therapeutics | Initiated Coverage: Buy | $27 | $3.05 | +785.25% | 1 | Jun 10, 2026 | |
| AAPG Ascentage Pharma Group International | Initiated Coverage: Buy | $45 | $19.40 | +131.96% | 1 | Jun 10, 2026 | |
| AVBP ArriVent BioPharma | Maintained: Buy | $45 | $29.58 | +52.13% | 6 | May 29, 2026 | |
| MGNX MacroGenics | Maintained: Buy | $9 | $4.37 | +106.19% | 9 | May 22, 2026 | |
| NUVB Nuvation Bio | Maintained: Buy | $12 | $6.22 | +92.93% | 3 | May 21, 2026 | |
| HROW Harrow | Maintained: Buy | $65 → $60 | $43.34 | +38.44% | 29 | May 14, 2026 | |
| ZYME Zymeworks | Reiterated: Buy | $40 | $23.62 | +69.35% | 3 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $18 | $8.02 | +124.44% | 118 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $17 | $16.88 | +0.71% | 3 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $0.7346 | +308.39% | 16 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 | $7.14 | +67.99% | 2 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 → $4 | $1.12 | +258.74% | 17 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $12.70 | +104.72% | 1 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $5.94 | +270.37% | 25 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $23.62 | +27.04% | 25 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $108 | $83.24 | +29.75% | 23 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $105 → $150 | $69.46 | +115.95% | 9 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $8.78 | +218.79% | 3 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 → $33 | $22.03 | +49.80% | 2 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 → $55 | $53.16 | +3.46% | 65 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $1.32 | +1,415.15% | 1 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $43 | $10.91 | +294.02% | 5 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $16 | $17.44 | -8.26% | 22 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $18 | $2.79 | +546.32% | 71 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $85 | $37.45 | n/a | 34 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $5.75 | n/a | 81 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $90.78 | n/a | 78 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $422 → $460 | $550.33 | n/a | 57 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.5 → $2 | $0.514 | n/a | 35 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.5 → $2 | $0.989 | n/a | 23 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $43.41 | n/a | 1 | Jan 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.56 | n/a | 30 | Jul 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.610351 | n/a | 15 | Jul 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.03 | n/a | 16 | Jul 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $140 | $7.41 | n/a | 4 | Jun 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $4 | $3.66 | n/a | 25 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.9866 | n/a | 23 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0012 | n/a | 10 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.34 | n/a | 16 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 14 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.89 | n/a | 14 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.83 | n/a | 8 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $1.33 | n/a | 14 | Dec 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.04 | n/a | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 → $120 | $11.80 | n/a | 7 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $10 | $11.79 | n/a | 14 | Mar 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $67 | $31.24 | n/a | 2 | Nov 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.38 | n/a | 26 | Jul 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.001 | n/a | 7 | Jul 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.59 | n/a | 19 | Jul 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.68 | n/a | 7 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.48065 | n/a | 11 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.41 | n/a | 10 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 18 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $13.22 | n/a | 4 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $23.73 | n/a | 1 | May 12, 2020 |
Veradermics
Jul 15, 2026
Initiated Coverage: Buy
Price Target: $170
Current: $112.54
Upside: +51.06%
Unicycive Therapeutics
Jun 30, 2026
Maintained: Buy
Price Target: $22
Current: $5.64
Upside: +290.01%
Kymera Therapeutics
Jun 29, 2026
Rated: Buy
Price Target: $117 → $155
Current: $111.34
Upside: +39.21%
Elicio Therapeutics
Jun 10, 2026
Initiated Coverage: Buy
Price Target: $27
Current: $3.05
Upside: +785.25%
Ascentage Pharma Group International
Jun 10, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $19.40
Upside: +131.96%
ArriVent BioPharma
May 29, 2026
Maintained: Buy
Price Target: $45
Current: $29.58
Upside: +52.13%
MacroGenics
May 22, 2026
Maintained: Buy
Price Target: $9
Current: $4.37
Upside: +106.19%
Nuvation Bio
May 21, 2026
Maintained: Buy
Price Target: $12
Current: $6.22
Upside: +92.93%
Harrow
May 14, 2026
Maintained: Buy
Price Target: $65 → $60
Current: $43.34
Upside: +38.44%
Zymeworks
Apr 10, 2026
Reiterated: Buy
Price Target: $40
Current: $23.62
Upside: +69.35%
Apr 9, 2026
Maintained: Buy
Price Target: $16 → $18
Current: $8.02
Upside: +124.44%
Apr 7, 2026
Maintained: Hold
Price Target: $14 → $17
Current: $16.88
Upside: +0.71%
Apr 7, 2026
Maintained: Buy
Price Target: $3
Current: $0.7346
Upside: +308.39%
Mar 26, 2026
Rated: Buy
Price Target: $12
Current: $7.14
Upside: +67.99%
Mar 25, 2026
Maintained: Buy
Price Target: $3 → $4
Current: $1.12
Upside: +258.74%
Mar 24, 2026
Initiated Coverage: Buy
Price Target: $26
Current: $12.70
Upside: +104.72%
Mar 18, 2026
Initiated Coverage: Buy
Price Target: $22
Current: $5.94
Upside: +270.37%
Mar 13, 2026
Reiterated: Buy
Price Target: $30
Current: $23.62
Upside: +27.04%
Mar 10, 2026
Reiterated: Buy
Price Target: $108
Current: $83.24
Upside: +29.75%
Feb 23, 2026
Maintained: Buy
Price Target: $105 → $150
Current: $69.46
Upside: +115.95%
Oct 6, 2025
Reiterated: Buy
Price Target: $28
Current: $8.78
Upside: +218.79%
Oct 3, 2025
Maintained: Buy
Price Target: $29 → $33
Current: $22.03
Upside: +49.80%
Sep 17, 2025
Maintained: Buy
Price Target: $53 → $55
Current: $53.16
Upside: +3.46%
Aug 26, 2025
Initiated Coverage: Buy
Price Target: $20
Current: $1.32
Upside: +1,415.15%
Aug 19, 2025
Maintained: Buy
Price Target: $43
Current: $10.91
Upside: +294.02%
Aug 14, 2025
Maintained: Buy
Price Target: $20 → $16
Current: $17.44
Upside: -8.26%
Aug 13, 2025
Maintained: Buy
Price Target: $20 → $18
Current: $2.79
Upside: +546.32%
Jul 15, 2025
Maintained: Buy
Price Target: $85
Current: $37.45
Upside: n/a
Jul 1, 2025
Maintained: Buy
Price Target: $8
Current: $5.75
Upside: n/a
May 14, 2025
Maintained: Buy
Price Target: $38
Current: $90.78
Upside: n/a
May 2, 2025
Maintained: Buy
Price Target: $422 → $460
Current: $550.33
Upside: n/a
Mar 27, 2025
Maintained: Buy
Price Target: $2.5 → $2
Current: $0.514
Upside: n/a
Feb 6, 2025
Maintained: Buy
Price Target: $1.5 → $2
Current: $0.989
Upside: n/a
Jan 9, 2025
Initiated Coverage: Buy
Price Target: $21
Current: $43.41
Upside: n/a
Jul 5, 2024
Rated: Hold
Price Target: n/a
Current: $3.56
Upside: n/a
Jul 5, 2024
Rated: Hold
Price Target: n/a
Current: $0.610351
Upside: n/a
Jul 5, 2024
Rated: Hold
Price Target: n/a
Current: $1.03
Upside: n/a
Jun 14, 2024
Reiterated: Buy
Price Target: $4 → $140
Current: $7.41
Upside: n/a
May 17, 2023
Reiterated: Buy
Price Target: $3 → $4
Current: $3.66
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $0.9866
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $0.0012
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $1.34
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $1.89
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $1.83
Upside: n/a
Dec 15, 2022
Maintained: Buy
Price Target: $6
Current: $1.33
Upside: n/a
Aug 19, 2022
Rated: Hold
Price Target: n/a
Current: $2.04
Upside: n/a
Mar 31, 2022
Maintained: Buy
Price Target: $3 → $120
Current: $11.80
Upside: n/a
Mar 23, 2022
Maintained: Buy
Price Target: $17 → $10
Current: $11.79
Upside: n/a
Nov 12, 2021
Maintained: Buy
Price Target: $67
Current: $31.24
Upside: n/a
Jul 2, 2021
Rated: Hold
Price Target: n/a
Current: $4.38
Upside: n/a
Jul 2, 2021
Rated: Hold
Price Target: n/a
Current: $0.001
Upside: n/a
Jul 2, 2021
Rated: Hold
Price Target: n/a
Current: $9.59
Upside: n/a
Oct 6, 2020
Rated: Hold
Price Target: n/a
Current: $3.68
Upside: n/a
Oct 6, 2020
Rated: Hold
Price Target: n/a
Current: $0.48065
Upside: n/a
Oct 6, 2020
Rated: Hold
Price Target: n/a
Current: $2.41
Upside: n/a
Oct 6, 2020
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
May 12, 2020
Downgraded: Hold
Price Target: n/a
Current: $13.22
Upside: n/a
May 12, 2020
Downgraded: Hold
Price Target: n/a
Current: $23.73
Upside: n/a